Rituximab in systemic sclerosis: A protocol for systematic review.

Medicine (Baltimore) · 2019 · PMC6756608 · PMID 31567948

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

The results of Pope et al [ 27 ] showed a favorable trend with the use of MTX over placebo, but the differences between groups were considered subtle.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.